Melanoma (Immunotherapy)

Adjuvant Therapy Well Tolerated in Pediatric Melanoma Patient

Published in Cancer Weekly, November 15th, 1999

Adjuvant immunotherapy with interferon alfa 2b (IFN(alpha)2b) was well tolerated in a pediatric melanoma patient.

W. Pietras and D. Wojcik from the Medical Academy, Poland, reported the case of a seven-year-old boy with melanoma who was treated at their facility. The case report was presented at the joint meeting of the International Society of Pediatric Oncology, the American Society for Pediatric Hematology/Oncology, and the 31st Annual Meeting of the International Society of Pediatric Surgical Oncology, held September 13-18, 1999, in Montreal, Canada.

"The incidence of melanoma has increased among people of white skin," wrote Pietras and Wojcik. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry